Christopher Case

Adiponectin, Inflammation, and the Expression of the Metabolic Syndrome in Obese Individuals: The Impact of Rapid Weight Loss through Caloric Restriction

Antonios M. Xydakis, Christopher Case, Peter H. Jones et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 288 citations · Full text

Medicine, Endocrinology, Physiology +17

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

Medicine, Pharmacology, Pharmacotherapy +15

Impact of weight loss on the metabolic syndrome

Christopher Case, Peter H. Jones, Kathleen W. Nelson et al. · Diabetes Obesity and Metabolism · 2002 · 202 citations

Medicine, Endocrinology, Physiology +14

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial

Keith Bowering, Christopher Case, John N. Harvey et al. · Diabetes Care · 2017 · 119 citations

Medicine, Endocrinology, Pharmacotherapy +17